Accelrys and Pfizer Extend Agreement for Global Deployment of Scientific Innovation Lifecycle Management Software

SAN DIEGO, May 7, 2013 /PRNewswire/ -- Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software, announced today that Pfizer, Inc. (NYSE: PFE) has signed a three-year contract with Accelrys, extending the companies' long-standing strategic partnership.  The agreement continues the global deployment of the Accelrys Enterprise Platform, Pipeline Pilot, Cheminformatics Suite and Modeling & Simulation software to Pfizer researchers worldwide.